title: Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors--response.
authors.affiliation: Authors' Affiliations: University of Pennsylvania, Philadelphia, Pennsylvania; Dana-Farber Cancer Institute, Boston, Massachusetts; and Ludwig Institute for Cancer Research, Epalinges, Lausanne, Switzerland.
authors.forename: Jaikumar
authors.initials: J
authors.lastname: Duraiswamy
authors.forename: Gordon J
authors.initials: GJ
authors.lastname: Freeman
authors.forename: George
authors.initials: G
authors.lastname: Coukos
mesh_terms: D000818:Animals; D060908:CTLA-4 Antigen / Q000276:immunology*; D019496:Cancer Vaccines / Q000276:immunology*; D005260:Female; D009374:Neoplasms, Experimental / Q000276:immunology*; D061026:Programmed Cell Death 1 Receptor / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D060908:CTLA-4 Antigen; D019496:Cancer Vaccines; D061026:Programmed Cell Death 1 Receptor